Shia LaBeouf has pleaded not guilty to petty theft and battery, charges stemming from an alleged incident in June.
Shia LaBeouf has pleaded not guilty to petty theft and battery, charges stemming from an alleged incident in June.
Where we choose to spend our money can have an environmental price.
A high prevalence of osteoarthritis is the major driving factor for the growth of the Chondroitin Sulfate market. The National Institute of Health (NIH) stated in its report that over 30 million adults in the United States were diagnosed with osteoarthritis (OA) in the year 2017.New York, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Chondroitin Sulfate Market - Growth, Trends, and Forecasts (2020 - 2025)" - https://www.reportlinker.com/p05993765/?utm_source=GNW The aging of the population and increasing obesity seen in all age groups are the prime causes of osteoarthritis in the country.Furthermore, increasing applications of chondroitin sulfate in various treatments is boosting the overall market growth for Chondroitin Sulfate globally. Not only in the treatment of osteoarthritis, but Chondroitin sulfate is also used in eye drops to treat dry eyes. Furthermore, it is also used in the solution to preserve cornea while transplantation during the cataract surgery.In April 2015, Santen Pharmaceutical Co., Ltd. launched New Sante de U ?, an OTC eye drop with Chondroitin sulfate sodium as an active ingredient for relieving eye fatigue and preventing eye disease.Key Market TrendsPharmaceuticals Segment is Expected to Hold a Significant Market ShareChondroitin sulfate is majorly used for the treatment of osteoarthritis. It is often used in combination with other ingredients such as glucosamine sulfate, manganese ascorbate, N-acetyl glucosamine or glucosamine hydrochloride. Chondroitin sulfate is also taken orally for heart attack, HIV/AIDS, heart disease, osteoporosis, joint pains because of the drugs used in the treatment of breast cancer, high cholesterol, muscle soreness after exercise, acid reflux, interstitial cystitis, Kashin-Beck disease, and psoriasis.Chondroitin sulfate is approved by the FDA as an eye drops to treat dry eyes and also used as a solution to preserve cornea during cataract surgery. In 2017, Imprimis Pharmaceuticals Inc., an ophthalmology-focused pharmaceutical company, announced that it has entered into a licensing agreement for the exclusive worldwide rights to Klarity, ophthalmic topical solution, and gel technology for patients with a dry eye disease (DED)Chondroitin sulfate ointments in combination with glucosamine sulfate, shark cartilage, and camphor can be used for pain of osteoarthritis. Some patients will inject chondroitin sulfate into muscles for osteoarthritis and some will insert chondroitin sulfate into the bladder for urinary tract infections, bladder conditions, or loss of bladder control. Thus there is a wide range of medicinal applications of chondroitin sulfate, the respective segment is expected to grow significantly.North America Holds the Major Share in Global Chondroitin Sulfate MarketThe well-established pharmaceutical industry in the North America region and increasing USFDA approvals for chondroitin sulfate can be credited to the growth of the Chondroitin Sulfate Market in the region.The high prevalence of osteoarthritis and increased use of cholesterol in cataract surgery and formulations for a drop in the eye are also a few factors that are enhancing the growth in North America. In November 2017, Gnosis launched the first dietary supplements with Mythocondro, the unique 100% vegan chondroitin sulfate similar to human synovial fluid into the USA market.The Asia Pacific is estimated to be the fastest-growing region during the forecast period owing to the high incidence of osteoarthritis and growing awareness about the chondroitin sulfate applications in personal care and nutritional supplements.Competitive LandscapeThe market is moderately competitive due to the presence of many manufacturers. Competition in the market is moderate due to the increasing investments in R&D for product innovation and the increasing efficiency of the product by launching new products into the market. With the rising prevalence of osteoarthritis and other indications where Chondroitin Sulfate is used, it is believed that few small to mid-sized companies will penetrate the market in the future.Reasons to Purchase this report:- The market estimate (ME) sheet in Excel format- 3 months of analyst supportRead the full report: https://www.reportlinker.com/p05993765/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
Age and occupation key to who gets the Pfizer/BioNTech jab first.
Dublin, Dec. 02, 2020 (GLOBE NEWSWIRE) -- The "Cocoa Powder Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering. The cocoa powder market is predicted to soar at a CAGR of 4.59% to reach a market size of US$3,022.869 million in 2025 from US$2,309.289 million in 2019. The cocoa industry is predicted to grow at a significant pace during the forecast period owing to the wide popularity of cocoa powder among the end-user industries at the global level. Its wide use as an important ingredient in the food and beverage industry is further propelling the market demand during the course of the forecast period.The growing production of cocoa powder is driven by its immense utilization in confectionery syrups and in the manufacturing of chocolates. Additionally, the increasing chocolate consumption along with the consumption of other food products like cocoa butter is further burgeoning the market demand during the forecast period. The market growth is further supported by the use of cocoa powder in foodservice restaurants as an ingredient in many food and beverages. Cocoa powder is being utilized as one of the important ingredients in the bakery industry, further augmenting the market demand over the next five years. The product is used on a large scale for producing baked products like cakes, pastries, cookies, and other sweet dishes.Apart from the food and beverage industry, cocoa powder is also utilized in cosmetics and personal care products. These include cocoa powder applications in skin care, hair care, bath and body products, and in soap making process. Soaps, facial masks, creams, lotions, shampoos, conditioners, lip balm, and massage oil are some of the products where the cocoa powder is extensively used. Hence, fueling market demand over the next five years.On the basis of Geography, Europe is projected to hold a significant market share in the global cocoa powder industry during the forecast period. The demand for chocolate along with the perceived health benefits is increasing the demand for cocoa powder in these regions. Additionally, manufacturers in the regions through innovation are continuously working on the product portfolio enhancement by manufacturing chocolates with different exotic flavours. On the other hand, the Asia Pacific region is projected to show high market growth prospects due to high cocoa consumption owing to the increasing disposable income of the end consumers who are willing to pay for premium cocoa products.The present novel coronavirus pandemic scenario has resulted in lockdowns in Europe and other parts of the world that serve as market for cocoa and chocolates. It is observed that mainstream chocolate consumption is quite stable, but the craft chocolate segment is facing difficulties amid COVID-19. In cocoa producing countries, like the Ivory Coast and Ghana, which produce more than 60% of the world's cocoa, it has been assessed that lockdowns may cause disruptions in the supply chain and this may lead to cocoa shortages. Hence, impacting the production of cocoa products including cocoa powder further leading to a decline in the market growth in 2020.The increasing consumption of cocoa powder due to its health benefits is further augmenting the market growth in the forecast period.Key Topics Covered: 1. Introduction2. Research Methodology3. Executive Summary3.1. Research Highlights4. Market Dynamics4.1. Market Drivers4.2. Market Restraints4.3. Market Opportunities4.4. Porters Five Forces Analysis4.5. Industry Value Chain Analysis5. Global Cocoa powder Market Analysis, by Type5.1. Introduction5.2. Natural Cocoa Powder5.3. Dutch-Process Cocoa Powder6. Global Cocoa powder Market Analysis, by Application6.1. Introduction6.2. Confectionary6.3. Bakery6.4. Beverages6.5. Cosmetics7. Global Cocoa powder Market Analysis, by Distribution Channel7.1. Introduction7.2. Online7.3. Offline8. Global Cocoa powder Market Analysis, by Geography8.1. Introduction8.2. North America8.2.1. North America Cocoa powder Market, By Type8.2.2. North America Cocoa powder Market, By Application8.2.3. North America Cocoa powder Market, By Distribution Channel8.2.4. By Country184.108.40.206. United States220.127.116.11.1. By Type18.104.22.168.2. By Application22.214.171.124.3. By Distribution Channel126.96.36.199. Canada188.8.131.52.1. By Type184.108.40.206.2. By Application220.127.116.11.3. By Distribution Channel18.104.22.168. Mexico22.214.171.124.1. By Type126.96.36.199.2. By Application188.8.131.52.3. By Distribution Channel8.3. South America8.4. Europe8.5. Middle East and Africa8.6. Asia Pacific9. Competitive Environment and Analysis9.1. Major Players and Strategy Analysis9.2. Emerging Players and Market Lucrativeness9.3. Mergers, Acquisitions, Agreements, and Collaborations9.4. Vendor Competitiveness Matrix10. Company Profiles 10.1. Cargill, Incorporated10.2. Barry Callebaut10.3. The Hershey Company10.4. Mars, Incorporated10.5. Cocoa Processing Company Limited10.6. Olam International10.7. KANY Corporation10.8. Indcre S.A. For more information about this report visit https://www.researchandmarkets.com/r/6fg1vx Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Meet the plus-size model who changed the fashion world
The vaccine has been shown to be 95% effective in preventing coronavirus.
Chinese fintech giant Ant Group is considering selling its 30% stake in Indian digital payment processor Paytm amid tensions between the two Asian neighbours and a toughening competitive landscape, people with direct knowledge of the matter said. Paytm, which is also backed by SoftBank Group Corp among others, was valued at about $16 billion (12 billion pounds) during its latest private fundraising round a year ago. At that valuation, Ant's stake in the Indian firm is worth about $4.8 billion.
Global streaming platform Starz formally launched its direct-to-consumer OTT app Lionsgate Play in India on Wednesday, after a Beta launch in early November. The service will cost INR699 ($9.50) annually, or INR99 ($1.35) monthly. The app is available to download across a range of platforms and devices including Google Play store, Apple app store and […]
She reveals she grew up with hearing problems in a new documentary
A US federal judge has struck down the Trump administration's October move to make changes to the H-1B visa programme that would have made it harder for the millions of existing holders to live and work in the country.
The third-largest investor in British housebuilder Countryside on Wednesday called for the company's chairman to be replaced and for its own representative to join the board as part of efforts to break up the company. The move follows previous letters to the board in which U.S.-based Browning West laid out its plan to split off the company's housebuilding arm from the Partnerships unit which helps build social housing alongside local government groups in Britain. Doing so would "enhance outcomes for all of Countryside's stakeholders, as well as ensure that the Company can continue to fulfil its important role in the community by addressing the UK's chronic housing shortage in a sustainable manner," it said.
From Her Majesty's inaugural Christmas address in 1952 to Meghan Markle's first holiday appearance with the royal family.From Harper's BAZAAR
The diagnostic specialty antibodies market is projected to grow with a CAGR of 5. 95%, during the forecast period. The advancements in DNA based technologies and diagnostics are expected to boost the market growth.New York, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Diagnostic Specialty Antibodies Market - Growth, Trends, and Forecast (2020 - 2025)" - https://www.reportlinker.com/p05993766/?utm_source=GNW In addition, the high number of patient pool undergoing diagnosis of HIV and growing demand for speciality diagnostics around the world is projected to fuel the market. Furthermore, the increase in the prevalence of diseases such as infectious diseases, influenza and cancer are expected to boost the diagnostic antibodies market.However, the high cost of development of antibodies in rapid diagnosis are expected to hamper the market growth. Moreover, the launch of new products and innovations in the diagnostic technologies is projected to boost the market. For instance, in August 2018, BioGenex has launched a range of antibodies that are used for cancer diagnosis.Key Market TrendsMonoclonal Antibodies are Expected to have Significant Growth Rate- Monoclonal antibodies play a vital role in the diagnosis of many infectious and chronic diseases such as cancer. The increase in the number of research on the monoclonal antibodies and its applications in various disease diagnosis are expected to boost the segment revenue.- Among the application segments, oncology application is anticipated to have a significant growth rate owing to recent drug approvals, a notable number of pipeline products and their expected commercialization.- For instance, in April 2017, Roche launched the monoclonal antibody for diagnosis of prostate cancer.- A growing number of cancer cases coupled with increasing awareness regarding the early diagnosis are expected to bolster the cancer application segment growth over the period.North America is Projected to Have Significant Market GrowthNorth America is projected to have a significant market share among the regions owing to the adaptation of various antibody diagnostics coupled with well-established healthcare infrastructure in the region. In addition, new product launches, high R&D investments and the growing number of cancer cases are some of the factors that are fuelling the market growth in this region. Moreover, the favorable government policies and increased funding from the government in cancer research expected to bolster the market growth. Due to the rising incidence of lifestyle-related diseases, cancer and infectious diseases in emerging countries of Asia-Pacific are expected to boost the Asia-Pacific diagnostic speciality antibodies market. According to the World Health Organization, each year cancer causes 7.9 million deaths around the world, of which 5.5 million from developing countries only.Competitive LandscapeThe diagnostic speciality antibodies market is moderately competitive with a notable number of market players. Market players are focusing on new product developments, collaborations and regional expansion to expand their market share. For instance, CytoDyn Inc has licenced its HIV drug leronlimab to IncellDx for diagnostic applications. The key market players operating in urgent care centres include F. Hoffmann-La Roche AG, Abcam plc, Bio-Rad Laboratories, Inc., Abbott Laboratories and Agilent Technologies, Inc. among others.Reasons to Purchase this report:- The market estimate (ME) sheet in Excel format- 3 months of analyst supportRead the full report: https://www.reportlinker.com/p05993766/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
Briton will defend his WBO, WBA and IFB belts in front of fans at Wembley Arena
Mr Justice Hayden said time was not on the side of many care home residents.
Bonmarche's 225 stores will continue to trade and there are no redundancies yet as administrators look to agree a rescue deal.
China on Wednesday rejected U.S. accusations it is weakening its enforcement of U.N. sanctions against North Korea, but said more efforts are needed toward reaching a political settlement and greater attention should be paid to the impact of the sanctions on ordinary North Koreans. Foreign ministry spokesperson Hua Chunying was responding to comments by the State Department’s deputy envoy for North Korean affairs, Alex Wong, in which he said China was no longer even attempting to enforce many of the sanctions, including a requirement to expel North Korean contract workers.
Shoppers have been queuing early on what has been dubbed 'Wild Wednesday'.
The jets were grounded worldwide after two fatal crashes in 2019
Dublin, Dec. 02, 2020 (GLOBE NEWSWIRE) -- The "Vision Care: Global Markets" report has been added to ResearchAndMarkets.com's offering. The current report provides a detailed analysis of the vision care devices market. This report will highlight the current and future market potential of vision care devices along and provide a detailed analysis of the competitive landscape. The report covers market projections for 2025 along with current market estimates. Epidemiology trends of major eye disorders, drivers, restraints, and opportunities will also be covered in the current report along with company profiles of the key market players. The report segments the market for vision care devices based on device, distribution channel, and geography. Based on device type, the market is broadly segmented into eyeglasses, contact lenses, intraocular lenses (IOLs), and artificial tears. Eyeglasses are further segmented into a single vision, bifocal and progressive. Contact lenses are further segmented into spherical lenses, toric lenses, multifocal contact lenses, and others. For market estimates, data will be provided for 2019 as the base year, with estimates for 2020 and forecast values for 2025. By geography, the market has been segmented into North America, Europe, the Asia-Pacific region, Latin America, and the Middle East and Africa. Detailed analysis of major countries such as the U.S., Canada, Germany, the U.K., Italy, France, Spain, Japan, China, India, Australia, Brazil, and Mexico will be covered in the regional segments. The Report Includes: 21 data tables and 11 additional tablesA brief overview of the global markets for vision care products and related technologiesAnalyses of the global market trends, with corresponding market analysis data for 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025Estimation of the actual market size and revenue forecasts for vision care, and market share analysis on the basis of product type with major regions and countries involvedInsights into the market potential for vision care devices, opportunities and restraints, regulatory updates, and technological trends and issues impacting the industryImpact of COVID-19 pandemic on the vision care marketInformation pertaining to strategic profiling of key companies (manufacturers and distributors) present across the globe and their competitive landscape, product launch strategies, and financial outlookKey merger and acquisition deals, joint ventures, collaborations, agreements, and partnerships within the medical devices industryProfile descriptions of the market-leading participants, including Alcon AG, Bausch + Lomb, Carl Zeiss AG, CooperVision Inc., EssilorLuxottica, and Seiko Opticals Market growth is attributed to factors such as the growing prevalence of blindness and vision impairment, a rise in the world's geriatric population, and growing collaborations between vision care companies and technology companies for the advent of technologically advanced products to address current unmet needs. According to the IAPB, nearly 1.1 billion people are considered to be affected by some form of vision loss: 43 million people are categorized as blind, about 553 million people are estimated to suffer from some form of moderate to severe visual impairment (MVSI), about 258 million people experience mild vision impairment and about 510 million suffer from near vision impairment. In addition, at least 1 billion more people need ongoing access to eye care services. High prevalence and the increasing burden of vision impairment is likely to drive the vision care market during the forecast period. Reasons for Doing This Study: Visual impairment is a global health concern that has a negative impact on both physical and mental wellbeing. Preventive blindness, a common vision disorder, represents a major challenge to the global healthcare system. Visual impairment is associated with loss of global productivity and high disability-adjusted life years (DALYs) and is responsible for significant healthcare spending. According to the International Agency for the Prevention of Blindness (IAPB), in 2020, nearly 1.1 billion people were considered to be affected by some form of vision loss; 43 million people are categorized as blind, about 553 million people are estimated to suffer from some form of Moderate and Severe Vision Impairment MSVI, about 258 million people experience mild vision impairment and about 510 million suffer from near vision impairment. In addition, at least 1 billion more people need ongoing access to eye care services. Globally, the leading causes of vision impairment are uncorrected refractive errors and cataracts. Refractory disorders, particularly myopia, are one of the common ailments seen across all age groups. The incidence of refractory disorders is estimated to have doubled in the last decade compared to past generations, with the rise driven by rapid changes in lifestyles, genetic disorders, and malnutrition. Refractory disorders, although increasingly prevalent, can be treated and are considered preventable ailments if addressed quickly. Market growth has been spurred by the introduction of technologically advanced products and the rise in the global visually impaired population. This report is designed to provide the reader with a background on vision care products, an analysis of the current factors influencing the market, and the tools to make decisions regarding expansion and penetration in this market. Key Topics Covered: Chapter 1 Introduction Study Goals and ObjectivesReasons for Doing This StudyScope of ReportInformation SourcesMethodologyGeographic BreakdownAnalyst's CredentialsCustom ResearchRelated Research Reports Chapter 2 Summary and Highlights Highlights of the Market for Vision Care Chapter 3 Clinical Overview Overview of Vision FunctionsVision Impairment OutlookCauses of Vision ImpairmentOverview of Common Eye ConditionsMyopiaHyperopiaAstigmatismPresbyopiaCataractsDry Eye Chapter 4 Epidemiological Insights Vision Impairment and BlindnessGlobal Estimates of Vision Impairment and BlindnessRegional Estimates of Vision Impairment and Blindness Chapter 5 Supply Chain Overview Supply Chain AnalysisRaw Materials SuppliersProduct ManufacturersProduct DistributorsRetailersEnd Consumers Chapter 6 Vision Care Market Dynamics Market DriversRise in Geriatric Population and Vision DisordersIncrease in Uptake of a New Generation of Contacts LensesRise in Volume of Cataract SurgeriesSoaring Screen Time and Increasing Incidence of Computer Vision SyndromeMarket RestraintsDearth in Eye Care Health Personnel and Low Affordability in Emerging CountriesIncreasing Surgical Procedures for Permanent Vision CorrectionHigh Threat of Counterfeit ProductsMarket TrendsInnovation of Personalized and 3D-Printed Spectacle LensesAdvent of Smart Eyeglasses and Smart Contact LensesIntensification of E-commerce as Preferred Distribution Channel Chapter 7 Impact of COVID-19 Pandemic on the Vision Care Market IntroductionSeverity of the DiseaseCOVID-19's Implications on the Vision Care IndustryMomentary Halt in Product ManufacturingTemporary Closure of Retail OutletsDelays in Elective Surgical ProceduresCancellation/Postponement of Eye ExamsTrade Restrictions and Supply DisruptionsOutline of COVID-19's Impact on the Vision Care MarketPossible Post-COVID-19 Vision Care Market Scenario Chapter 8 Market Breakdown by Product Type Global Market for Vision Care, by Product TypeEyeglass LensesMarket Size and ForecastMarket Analysis by RegionMarket Analysis by Product DesignContact LensesMarket Size and ForecastMarket Analysis by RegionMarket Analysis by Product DesignIntraocular LensesMarket Size and ForecastMarket Analysis by RegionOther Vision Care ProductsMarket Size and Forecast Chapter 9 Market Breakdown by Region Global Market for Vision Care, by RegionNorth AmericaMarket Size and ForecastMarket AnalysisMarket Share by CountryEuropeMarket Size and ForecastMarket AnalysisMarket Share by CountryAsia-PacificMarket Size and ForecastMarket AnalysisMarket Share by CountryLatin AmericaMarket Size and ForecastMarket AnalysisMarket Share by CountryMiddle East and AfricaMarket Size and ForecastMarket Analysis Chapter 10 Competitive Landscape Global Competitive OverviewEyeglass LensesContact LensesIntraocular LensesKey Recent Product Approvals/LaunchesStrategic Deals and Collaborations Chapter 11 Company Profiles AlconBausch + LombCarl ZeissCoopervision Inc.EssilorluxotticaHoya Corp.Johnson & JohnsonMeniconRodenstockSeiko OpticalsSynergeyes Chapter 12 Appendix: Acronyms For more information about this report visit https://www.researchandmarkets.com/r/35ke4b Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900